Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_assertion type Assertion NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_head.
- NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_assertion description "[The expression levels of the three adhesion proteins were quantitatively different in the cell lines but the composite CD24(low/-)CD44(+)EpCAM(+) breast cancer stem cell phenotype was shown to exist as a small fraction, between 0.1% and 1.2%, in all breast cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_provenance.
- NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_assertion evidence source_evidence_literature NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_provenance.
- NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_assertion SIO_000772 21266162 NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_provenance.
- NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_assertion wasDerivedFrom befree-2016 NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_provenance.
- NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_assertion wasGeneratedBy ECO_0000203 NP867602.RAw2qjIbutNraZ0ODon-6Ux_Apnzee8xUbzKYTb3E-_Tc130_provenance.